GridAI Technologies Corp.(GRDX)

Biotechnology · Edinburgh, FL

$4.28+0.45 (+11.75%)

Delayed quote: Oct 6, 2026, 11:10 AM EDT

Price/FCF Ratio: N/A

Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/FCF ratio is N/A as of 2026-10-06T15:12:21.068Z.

Stored calculation inputs

Calculation as of: 2026-10-06T15:12:21.068Z.

Quote observation: 2026-10-06T15:10:06.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 30,521,206
TTM free cash flow · period ending 2026-06-30: -8,120,882

FMP input reference: 786381cf23009ce26769892c1927912581314c354aa2592277191dd3add0e379

P/E Ratio|FCF Growth|Operating Margin|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

GRDX Price/FCF Ratio Metrics

PRICE/FCF RATIO

N/A

GRDX Competitors' Price/FCF Ratio

GRDX

GridAI Technologies Corp.

Current

Market Cap

$30.52M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ONMD

OneMedNet Corporation

vs GRDX

Market Cap

$29.44M

Price/FCF Ratio

N/A

TTM Avg

2.82

3Y Avg

2.82

5Y Avg

2.82

CRVO

CervoMed Inc.

vs GRDX

Market Cap

$29.91M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BYSI

BeyondSpring Inc.

vs GRDX

Market Cap

$30.84M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CNTX

Context Therapeutics Inc.

vs GRDX

Market Cap

$31.16M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ATYR

aTyr Pharma, Inc.

vs GRDX

Market Cap

$28.81M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MIRA

MIRA Pharmaceuticals, Inc.

vs GRDX

Market Cap

$31.03M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MDXH

MDxHealth S.A.

vs GRDX

Market Cap

$31.10M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BDMD

Baird Medical Investment Holdings Limited

vs GRDX

Market Cap

$31.36M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NSYS

Nortech Systems Incorporated

vs GRDX

Market Cap

$31.77M

Price/FCF Ratio

16.44

TTM Avg

17.64

3Y Avg

23.73

5Y Avg

19.18

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
GridAI Technologies Corp. (GRDX)	$30.52M	N/A	N/A	N/A	N/A
OneMedNet Corporation (ONMD)vs ›	$29.44M	N/A	2.82	2.82	2.82
CervoMed Inc. (CRVO)vs ›	$29.91M	N/A	N/A	N/A	N/A
BeyondSpring Inc. (BYSI)vs ›	$30.84M	N/A	N/A	N/A	N/A
Context Therapeutics Inc. (CNTX)vs ›	$31.16M	N/A	N/A	N/A	N/A
aTyr Pharma, Inc. (ATYR)vs ›	$28.81M	N/A	N/A	N/A	N/A
MIRA Pharmaceuticals, Inc. (MIRA)vs ›	$31.03M	N/A	N/A	N/A	N/A
MDxHealth S.A. (MDXH)vs ›	$31.10M	N/A	N/A	N/A	N/A
Baird Medical Investment Holdings Limited (BDMD)vs ›	$31.36M	N/A	N/A	N/A	N/A
Nortech Systems Incorporated (NSYS)vs ›	$31.77M	16.44	17.64	23.73	19.18

Free Cash Flow Valuation

P/FCF Ratio

N/A

FCF Yield

N/A

Price/FCF Ratio Formula & Definition

P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Price/FCF Ratio: N/A

GRDX Price/FCF Ratio Metrics

GRDX Competitors' Price/FCF Ratio

Free Cash Flow Valuation

Price/FCF Ratio Formula & Definition

Related Metrics